SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001564590-21-035794
Filing Date
2021-07-06
Accepted
2021-07-06 06:43:25
Documents
7
Period of Report
2021-07-06

Document Format Files

Seq Description Document Type Size
1 6-K tlc-6k_20210731.htm 6-K 25214
2 EX-99.1 tlc-ex991_6.htm EX-99.1 12030
3 EX-99.2 tlc-ex992_8.htm EX-99.2 92433
4 GRAPHIC glnhh1hqpn2j000002.jpg GRAPHIC 48106
5 GRAPHIC glnhh1hqpn2j000001.jpg GRAPHIC 21642
6 GRAPHIC glnhh1hqpn2j000004.jpg GRAPHIC 48106
7 GRAPHIC glnhh1hqpn2j000003.jpg GRAPHIC 21642
  Complete submission text file 0001564590-21-035794.txt   323329
Mailing Address 2F, 3 YUANQU STREET NANGANG DISTRICT TAIPEI CITY F5 11503
Business Address 2F, 3 YUANQU STREET NANGANG DISTRICT TAIPEI CITY F5 11503 886 2 2655 7377
Taiwan Liposome Company, Ltd. (Filer) CIK: 0001722890 (see all company filings)

IRS No.: 000000000 | State of Incorp.: F5 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38746 | Film No.: 211072448
SIC: 2834 Pharmaceutical Preparations